$Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil$

Refractory pemphigus vulgaris treated with rituximab and mycophenolate mofetil

The main treatment for pemphigus vulgaris are systemic corticosteroids and immunosuppressive agents, but due to adverse reactions and therapeutic failure, new drugs such as rituximab and mycophenolate mofetil have been used. In this case report are described two cases of severe pemphigus vulgaris re...

Full description

Bibliographic Details
Main Authors:	Stephanie Del Rio Navarrete Biot, Joanna Pimenta de Araujo Franco, Ricardo Barbosa Lima, Henrique Novo Costa Pereira, Luiz Paulo José Marques, Carlos José Martins
Format:	Article
Language:	English
Published:	Sociedade Brasileira de Dermatologia 2014-12-01
Series:	Anais Brasileiros de Dermatologia
Subjects:	Antibodies, monoclonal Immunosuppressive agents Pemphigus
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0365-05962014000600980&tlng=en

Similar Items

Four cases of recalcitrant pemphigus vulgaris salvaged with rituximab
by: Samyak Ganjre, et al.
Published: (2017-01-01)

Gastrointestinal cytomegalovirus disease in a patient with pemphigus vulgaris treated with corticosteroid and mycophenolate mofetil
by: Luiza Barbosa Oliveira, et al.
Published: (2017-03-01)

Real world evidence: Patients with refractory pemphigus treated with Rituximab
by: Vagiani Perifani, et al.
Published: (2021-12-01)

Refractory pemphigus vulgaris successfully treated with ofatumumab
by: Daniel M. Klufas, MD, et al.
Published: (2020-08-01)

Off-label use of rituximab in dermatology: pemphigus treatment
by: Lislaine Bomm, et al.
Published: (2013-08-01)

Comparing the short-term therapeutic effects and safety profiles of rituximab therapy in pemphigus vulgaris patients either early treated or later than six months
by: Kamran Balighi, et al.
Published: (2019-05-01)

Pemphigus vulgaris successfully treated with ocrelizumab following rituximab allergy
by: Gabrielle Benesh, BS, et al.
Published: (2021-10-01)

Serum sickness following rituximab therapy in a patient with pemphigus vulgaris: A case report
by: Mohamad Y. Khatib, et al.
Published: (2021-02-01)

Case report: Mounded and refractory keratoses (MARK), a novel presentation of pemphigus vulgaris
by: Stephanie T. Le, et al.
Published: (2023-01-01)

Pemphigus vulgaris with refractory gingival ulcerations, successfully treated with rituximab—A case report
by: Mateja Dolenc‐Voljč, et al.
Published: (2022-09-01)

Rituximab Therapy for Treatment of Pemphigus in Southeast Asians
by: Kanokrungsee S, et al.
Published: (2021-04-01)

Evaluation of cases of pemphigus vulgaris and pemphigus foliaceus from a reference service in Pará state, Brazil
by: Carla Andréa Avelar Pires, et al.
Published: (2014-07-01)

Kaposi's sarcoma in a patient with pemphigus vulgaris mimicking exacerbation of pemphigus
by: Kamran Balighi, et al.
Published: (2023-05-01)

A Comparison of Azathioprine and Mycophenolate Mofetil as Adjuvant Drugs in Patients with Pemphigus: A Retrospective Cohort Study
by: Siriorn Sukanjanapong, et al.
Published: (2019-12-01)

Sustained CD19+CD27+ Memory B Cell Depletion after Rituximab Treatment in Patients with Pemphigus Vulgaris
by: Katharina Boch, et al.
Published: (2022-03-01)

Subtype transition from pemphigus vulgaris to pemphigus foliaceus
by: Ty Gilkey, BS, et al.
Published: (2023-01-01)

A comparative effectiveness research of azathioprine and cyclophosphamide on the clinical and serological response in pemphigus vulgaris
by: Kabir Sardana, et al.
Published: (2016-01-01)

Novel use of dupilumab in pemphigus vulgaris and pemphigus foliaceus
by: Christina Jiang, BS, MS, et al.
Published: (2023-12-01)

Pemphigus vulgaris
by: Vijeev Vasudevan, et al.
Published: (2008-01-01)

Efficacy and safety of biosimilar rituximab in patients with pemphigus vulgaris: a prospective observational study
by: Roja Toosi, et al.
Published: (2021-01-01)

The cutaneous form of pemphigus vulgaris of the pemphigus chancre type: clinical and therapeutic implications
by: Natalia Welc, et al.
Published: (2024-02-01)

Pemphigus Vulgaris in the Mouth and Esophageal Mucosa
by: Angelo Gualberto de Macedo, et al.
Published: (2018-06-01)

A rare new presentation of pemphigus vulgaris
by: Nikoo Mozafari, et al.
Published: (2022-06-01)

Role of Rituximab in the Treatment of Pemphigus Vulgaris: Patient Selection and Acceptability
by: Ciolfi C, et al.
Published: (2022-11-01)

Management of pemphigus vulgaris with rituximab: A case report and brief review on emerging treatment options
by: Massillamani Francis, et al.
Published: (2019-01-01)

Application of reflectance confocal microscopy in the diagnosis of pemphigus vulgaris and pemphigus foliaceus
by: Marta Kurzeja
Published: (2022-07-01)

Considerations for the use of immunosuppression for the management of pemphigus during the COVID-19 pandemic with a focus on rituximab: Case reports from a single center experience in Australia
by: Ben Koszegi, et al.
Published: (2023-03-01)

Pemphigus vulgaris and foliaceus localized to the nose: Report of 2 cases
by: Mohannad G. Safadi, BS, et al.
Published: (2021-09-01)

Efficacy and safety of biosimilar rituximab in the treatment of pemphigus vulgaris: a single center experience of 12 cases
by: Federico Bardazzi, et al.
Published: (2022-01-01)

Is It Time to Reconsider Rituximab Dosing Regimens for Pemphigus Vulgaris?
by: Christian Ciolfi, et al.
Published: (2024-01-01)

Pre-infusion checklist for rituximab in pemphigus vulgaris patients: clinical audit
by: Farah Sagheer, et al.
Published: (2023-07-01)

Rituximab‐induced psoriasis in a patient with pemphigus vulgaris: A case report and literature review
by: Leila Ghadirzade Arani, et al.
Published: (2024-03-01)

Evaluation of the possible association between acantholysis and anti‐desmogleins 1 and 3 values in pemphigus vulgaris and pemphigus foliaceus
by: Maryam Mobarakabadi, et al.
Published: (2019-12-01)

Severe Multi-Resistant Pemphigus vulgaris: prolonged remission with a single cycle of Rituximab
by: Isabela Soubhia Corral, et al.
Published: (2013-08-01)

Childhood Pemphigus Vulgaris during COVID-19 Outbreak Successfully Treated with Prednisone and Azathioprine: A Case Report and Literature Review
by: Pamela Vezzoli, et al.
Published: (2022-11-01)

Acquired Hemophilia in Associaton With Pemphigus Vulgaris;An Uncommon Coexistence: A Case Report
by: Kamran Balighi, et al.
Published: (2021-10-01)

Simultaneous endemic pemphigus foliaceus and psoriasis vulgaris in Peru – immunogenetic or environmental factors?
by: Willy Ramos, et al.
Published: (2021-06-01)

Rituximab/IVIG in pemphigus – a 10-year study with a long follow-up
by: Issam Hamadah, et al.
Published: (2019-02-01)

Unilateral Dyshidrosiform Pemphigus Vulgaris
by: Manju Daroach, et al.
Published: (2020-06-01)

Expression of HLA-G in the Skin of Patients with Pemphigus Vulgaris
by: Fathemeh Yari, et al.
Published: (2008-03-01)